MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
1. Triple Helix _ Sectors
3. Government ... Funders, Regulators, Policy Makers, Conveners
*Government: International
Europe
*Government: Europe
Sweden
Industry: Sweden
Mentice AB Medical Simulation
Endovascular
Parents
*Technologies Driving ADL/MMS
Mentice AB Medical Simulation
Children
“This is a colossal disappointment,” Mehdi Shishehbor, director of endovascular services at the Cleveland Clinic, said in a phone interview. “I think many companies are going to go back to the drawing board.”
*2024: Pivotal human clinical trial as part of its Investigational Device Exemption (“IDE”) application for its LIBERTY® Endovascular Robotic Surgical System
*Architects: Catheters
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Devices, NeuroTechnology, Services & Health Information Technology)
*Architects: Surgical & Diagnostic Technology _ Vascular, PAD (Peripheral Arterial Disease & CLI (Critical Limb Ischemia)
*Architects: Surgical Robotics
*Architects: Surgical Technology_Catheters
*Company's product include cerebral endovascular treatment devices for tortuous and delicate vessels enabling insertion of a catheter in an appropriate position for treatment.
*Developing next-generation telerobotic solutions for critical endovascular interventions
*Endovascular medical devices for neuro, peripheral, and coronary vascular access applications.
*Endovascular robotics and steerable guidewires designed to enhance precision in navigating the vascular system.
*Endovascular treatments with the Resorbable Fibrillated Scaffold (RFS)
*New class of endovascular procedures using Endoportal Control
*Pioneers: Stroke
*Surgical device manipulator for endovascular practitioners to significantly reduce exposure to ionizing radiation with a robotic system for conducting minimally invasive coronary procedures
*Synchron's Stentrode BCI is a non-surgical endovascular brain-computer interface platform designed to help improve mobility, communication and independence for individuals with paralysis.
+ RTx Endovascular System + STx Surface Pad System + Accutrol™ Catheter
2004: MRI Guided Rapid Laser Endovascular Photoacoustic Recanalization for Hyperacute Stroke -CIMIT
2011: AcelRx Gets $40M in IPO ... Lower than Forecasts (2011)
2022: Centerline Biomedical Raises $33 Million in Series B Financing
2023: Stryker completes acquisition of Cerus Endovascular
2024: Healionics’ Stargraft AV Dialysis Access Device Receives FDA Breakthrough Device Designation
2024: Jupiter Endovascular may have solved a critical catheter challenge
2025: Microbot Medical launches Liberty endovascular robot in the U.S.
2025: NextBioMedical Receives IDE Approval for Pivotal Trial of Nexsphere-F Genicular Artery Embolization Device
2025: XCath reports first human use of neuro-endovascular surgical robot
2026: Stereotaxis Expands Endovascular Reach with $45M Robocath Acquisition
A safe and reliable device for endovascular biopsy University of California System: University of California, San Francisco
Catheter-based Reprieve® Endovascular Temperature Therapy System permits rapid changes in patient core body temperature and prec
Centerline Biomedical is commercializing a Cleveland Clinic technology leveraging electromagnetic tracking and anatomical mapping to allow surgeons to visualize endovascular interventions in real time without continuous radiation.
Cerus Endovascular
Cerus Endovascular designs and develops neurointerventional devices for the treatment of intracranial aneurysms.
Change the treatment model of CHF by commercializing a pocket circulatory assist device that can be endovascularly implanted sim
Commercial-stage medical device company with an approved endovascular abdominal aortic aneurysm pressure management system and c
Developer of innovative cardiology, endovascular, pain management, and orthopaedic devices.
EarLens is led by William Facteau, the former general manager of Abbott Vascular's endovascular business (2014)
EKOS's EkoSonic Endovascular System Gets European Clearance to Treat Pulmonary Embolism (2011)
Endovascular
Endovascular Engineering (E2)
Endovascular Institute
EVE-Endovascular Training System-CIMIT
Finance & Acquisition: Jupiter Endovascular
Finance & Acquisitions: Endovascular Engineering (E2)
Garret Gomes, VP, product development, Jupiter Endovascular (2024)
Guidewire technology for endovascular navigation.
Guidewires
Intact Vascular
It’s the first time an endovascular device—which uses a catheter to slide inside arteries—has won approval to fight pulmonary embolisms in Europe
Johnson & Johnson has finalized the acquisition of Micrus Endovascular, a manufacturer of "bioactive" coils used for treating an
Jupiter Endovascular
Key People: Endovascular Engineering (E2)
Key People: Jupiter Endovascular
Laser Endovascular Photoacoustic Recanalization (LEPAR) device
Maker of devices used in endovascular surgeries.
Micrus Endovascular
Minimally Invasive Stroke Therapy:EVE(Endovascular Treatment Training)-CIMIT
Minimally invasive, endovascular procedure guidance
next-generation transluminally placed (via catheter) endovascular grafts (often referred to as stent grafts), for the treatment
Organization & Developments: Endovascular Engineering (E2)
Organization & Developments: Jupiter Endovascular
R&D of endovascular temperature therapy system to treat acute ischemic, inflammatory conditions
Rapid endovascular vessel occlusion and blood flow interruption
Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)
Robocath
Spectranetics Corporation (NSDQ: SPNC)
The early stage research and development medical device company has developed a drug delivery device for the treatment of restenosis (re-blockage of blood vessels) and is developing devices for endovascular debulking (clearing of blocked blood vessels).
Treovance Endovascular Abdominal Stent Graft Being Implanted in Initial Patients